TE_38969
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluYh3 |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 1.13 |
| Counts of samples | TCGA_tumor:0; TCGA_normal:0; GTEx:0 |
| TSS | chrY(-):18169804 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38969.1 | - | Intergenic | Non-coding | Non-coding | chrY(-):18147441,18147461,18147839,18149555,18169608,18169805 |
| teRNA_38969.2 | - | Intergenic | Non-coding | Non-coding | chrY(-):18143855,18143875,18147839,18149555,18169608,18169805 |
| teRNA_38969.3 | - | Intergenic | Other | MQDGMGKGVALVDGHRVGDPVSTVHDNASGAPKGIEGQHIPDGHVHGRGIEGLKHNLSHFLSVVLGVQWVLGQQHWLLLRGPMQLIVEVVPDLLHVVPVGDDAMLDGVLQRQNAALALGFIAHVGVLLAHVHHHALVSGEPNGGGKHGLGSIVPCKASFAHARAIVNDERSDLFFYCDGQRSGTEERQKNKTKSLCVAQAGLQWHDTDSLQPLPPRFG* | chrY(-):18116134,18116154,18147320,18147461,18147839,18149555,18169608,18169805 |
| teRNA_38969.4 | - | Intergenic | Non-coding | Non-coding | chrY(-):18116134,18116154,18147839,18149555,18169608,18169805 |
| teRNA_38969.5 | - | Intergenic | Other | MQDGMGKGVALVDGHRVGDPVSTVHDNASGAPKGIEGQHIPDGHVHGRGIEGLKHNLSHFLSVVLGVQWVLGQQHWLLLRGPMQLIVEVVPDLLHVVPVGDDAMLDGVLQRQNAALALGFIAHVGVLLAHVHHHALVSGEPNGGGKHGLGSIVPCKASFAHARAIVNDERSDLFFYCDGQRSGTEERQKNKTKSLCVAQAGLQWHDTDSLQPLPPRFG* | chrY(-):18143855,18143875,18147320,18147461,18147839,18149555,18169608,18169805 |
| teRNA_38969.6 | - | Intergenic | Non-coding | Non-coding | chrY(-):18142239,18142259,18147839,18149555,18169608,18169805 |
| teRNA_38969.7 | - | Intergenic | Non-coding | Non-coding | chrY(-):18147441,18147461,18169608,18169805 |
| teRNA_38969.8 | - | Intergenic | Non-coding | Non-coding | chrY(-):18116134,18116154,18169608,18169805 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
